)
Edge10 Jul 2026
Inside Take-Two: The Grand Anticipation
The story of how Take-Two Interactive built the empire behind Grand Theft Auto, Red Dead Redemption, and one of gaming's largest mobile portfolios.
Sun Pharma Advanced Research Company
Sun Pharma Advanced Research Company (SPARC) investor relations material
Sun Pharma Advanced Research Company Q1 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 26/27 earnings summary10 Aug, 2026
Executive summary
Unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, were approved by the Board on August 10, 2026.
Requests for reclassification of certain promoter group individuals to public category were approved, pending regulatory approvals.
Financial highlights
Standalone revenue from operations for Q1 FY27 was ₹3,992 lakhs, compared to ₹964 lakhs in Q1 FY26 and ₹1,84,002 lakhs in Q4 FY26 (which included a one-time PRV sale).
Standalone net loss for Q1 FY27 was ₹2,098 lakhs, versus a net loss of ₹5,203 lakhs in Q1 FY26 and a net profit of ₹1,76,070 lakhs in Q4 FY26.
Consolidated revenue from operations for Q1 FY27 was ₹3,992 lakhs, with a consolidated net loss of ₹2,078 lakhs.
Basic and diluted EPS for Q1 FY27 was ₹(0.65) standalone and ₹(0.64) consolidated.
Outlook and guidance
No explicit forward-looking guidance provided, but recent developments such as the PRV sale and licensing agreement termination may impact future quarters.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Sun Pharma Advanced Research Company
- Exceptional PRV income drove a major profit rebound and strengthened equity in FY26.SPARC
Q4 25/26 - Q3 FY26 net loss widened, revenue declined, and a US FDA PRV was granted for Sezaby®.SPARCQ3 25/26
- Lead programs SCD153 and MUC1 ADC/SBO-154 advance, driven by partnerships and cost savings.SPARCR&D Day 2026
- Losses narrowed but remain significant; promoter support continues to underpin operations.SPARCQ2 25/26
- Net loss narrowed in Q1 FY26 as revenue declined and R&D focus continued.SPARCQ1 25/26
- Prioritizing oncology and immunology assets, pursuing cash catalysts and clinical milestones.SPARCStatus Update
- Net loss deepened in Q2 FY25 amid falling revenues and persistent high expenses.SPARCQ2 24/25
- Net loss persists amid declining revenue, with operations supported by promoter group backing.SPARCQ1 24/25
- SPARC narrowed its annual loss and plans to raise up to Rs. 1,800 crores for future growth.SPARCQ4 24/25
Next Sun Pharma Advanced Research Company earnings date
Q2 26/272 Nov, 2026
Sun Pharma Advanced Research Company
Next Sun Pharma Advanced Research Company earnings date
Q2 26/272 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage